Searched for
HUZAIFA KHORAKIWALA
Wockhardt, its directors settle case with SebiThe three directors include Habil Khorakiwala, Murtaza Khorakiwala and Huzaifa Khorakiwala. The case relates to Sebi's investigation into t...- Buy Wockhardt, target Rs 505: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 505 and a stoploss at Rs 488 from entry point.
- Sell Wockhardt, target Rs 705: Manas JaiswalSell Wockhardt Ltd. at a price target of Rs 705.0 and a stop loss at Rs 741 from entry point.
- Buy Wockhardt, target Rs 880: Kunal BothraBuy Wockhardt Ltd. at a price target of Rs 880.0 and a stop loss at Rs 800 from entry point.
- Buy Wockhardt, target Rs 840: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 840.0 and a stop loss at Rs 810 from entry point.
- Buy Wockhardt, target Rs 795: Shrikant ChouhanBuy Wockhardt Ltd. at a price target of Rs 795.0 and a stop loss at Rs 750 from entry point.
- Buy Wockhardt, target Rs 985: Shrikant ChouhanBuy Wockhardt Ltd. at a price target of Rs 985.0 and a stop loss at Rs 940 from entry point.
- Buy Wockhardt, target Rs 850: Kunal BothraBuy Wockhardt Ltd. at a price target of Rs 850.0 and a stop loss at Rs 795 from entry point.
- Buy Wockhardt, target Rs 800: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 800.0 and a stop loss at Rs 775 from entry point.
- Buy Wockhardt, target Rs 775: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 775.0 and a stop loss at Rs 750 from entry point.
- Buy Wockhardt, target Rs 825: Kunal BothraBuy Wockhardt at a price target of Rs 825.0 and a stop loss at Rs 725 from entry point.
- Buy Wockhardt, target Rs 770: Dr CK NarayanBuy Wockhardt at a price target of Rs 770 and a stop loss at Rs 745 from entry point.
- Buy Wockhardt, target Rs 780: Kunal BothraBuy Wockhardt at a price target of Rs 780 and a stop loss at Rs 700 from entry point.
- Huzaifa Khorakiwala will launch an angel fund to support healthcare companiesIt will raise its corpus in multiple rounds and expects to close the first round by March 2017, raising more than half the total amount.
- Not interested in biz: Khorakiwala JrHuzaifa Khorakiwala, the son of Wockhardt promoter Habil Khorakiwala who was recently promoted to the post of wholetime director, says he i...
- Wockhardt won't sell head-office in Mumbai: DirectorPharma major, Wockhardt on Friday said that it was looking at raising funds and was evaluating various options but selling its head-office,...
- GeNext promoters step into company boardroomsPiramal Healthcare on Wednesday inducted Nandini Piramal, daughter of promoters Ajay and Swati Piramal, on to the company board, as part of...
- Murtaza’s elevation to top post at Wockhardt strengthens gripWockhardt chairman and managing director Habil Khorakiwala’s move to step down from the post of MD and appoint younger son Murtaza Khorakiw...
- Wockhardt to set up pharma SEZPharmaceutical company Wockhardt Ltd has entered into a Memorandum of Understanding with Maharashtra Industrial Development Corporation (MI...
- Wockhardt signs MoU for pharma SEZ in M’rashtraPharmaceutical and biotechnology major Wockhardt signed a memorandum of understanding (MoU) with Maharashtra Industrial Development Corpora...
Load More- Buy Wockhardt, target Rs 880: Kunal Bothra
